Market Research Logo

United States Cataract Surgery Devices Market Outlook to 2022

United States Cataract Surgery Devices Market Outlook to 2022

Summary

GlobalData’s new report, United States Cataract Surgery Devices Market Outlook to 2022, provides key market data on the United States Cataract Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Phacoemulsification Equipment and Ophthalmic Viscoelastic Devices (OVD).

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cataract Surgery Devices market segements - Phacoemulsification Equipment and Ophthalmic Viscoelastic Devices (OVD).
  • Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for each of the market segements.
  • Global corporate-level profiles of key companies operating within the United States Cataract Surgery Devices market.
  • Key players covered include Alcon, Inc., Abbott Medical Optics, Inc., Bausch & Lomb Incorporated, Carl Zeiss AG and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cataract Surgery Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cataract Surgery Devices Market, United States
3.1 Cataract Surgery Devices Market, United States, Revenue ($m), 2008-2015
3.2 Cataract Surgery Devices Market, United States, Revenue ($m), 2015-2022
3.2.1 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), by Segment, 2008-2015
3.2.2 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), by Segment, 2015-2022
3.3 Cataract Surgery Devices Market, United States, Volume (Units), 2008-2015
3.4 Cataract Surgery Devices Market, United States, Volume (Units), 2015-2022
3.4.1 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), by Segment, 2008-2015
3.4.2 Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), by Segment, 2015-2022
3.5 Cataract Surgery Devices Market, United States, Average Price ($), 2008-2022
3.6 Cataract Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2014-2015
3.7 Cataract Surgery Devices Market, United States, Company Share by Revenue ($m), 2015
4 Overview of Key Companies in United States, Cataract Surgery Devices Market
4.1 Abbott Medical Optics, Inc.
4.1.1 Company Overview
4.2 Bausch & Lomb Incorporated
4.2.1 Company Overview
4.3 Carl Zeiss AG
4.3.1 Company Overview
4.4 Alcon, Inc.
4.4.1 Company Overview
5 Cataract Surgery Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Johnson & Johnson to Acquire Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion
6.2 Venture Financing
6.2.1 ReVision Optics Secures USD10 Million from Square 1 Bank
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jul 26, 2016: DeGen Medical Receives Clearance of F1 MPS System for JOUST Minimally Invasive Surgical Procedure
7.1.2 Jul 14, 2016: Glaukos Announces Planned Retirement of Chief Financial Officer Richard L. Harrison
7.1.3 Jun 01, 2016: Biogen’s Investigational Alzheimer’s Disease Treatment Aducanumab Accepted into European Medicines Agency’s PRIME Program
7.1.4 May 18, 2016: Amgen To Present Data on Vectibix (panitumumab) At ASCO 2016
7.1.5 Mar 17, 2016: Medstar Harbor Hospital's Use Of Capnography Respiratory Monitoring Helps Protect Patients On Pain Medication
7.1.6 Mar 10, 2016: VisionCare Ophthalmic Technologies Announces Appointment of Industry Veteran, Thierry Clidiere, to its Board of Directors
7.1.7 Mar 04, 2016: Wake Forest Baptist Announces Starbuck Promoted to Vice President Position
7.1.8 Mar 04, 2016: Wake Forest Baptist Announces Lord Promoted to Vice President Position
7.1.9 Mar 04, 2016: Wake Forest Baptist Names New Chair of Emergency Medicine
7.1.10 Jan 29, 2016: Intersect ENT Announces NUB Status 1 Designation for PROPEL Sinus Implant in Germany
7.1.11 Jan 26, 2016: Polyganics Receives FDA 510(k) Clearance for Nerve Capping Device NEUROCAP
7.1.12 Jan 25, 2016: Quidel Receives CE Mark for Its New Sofia Fluorescent Immunoassay for Diagnosis of Pneumococcal Pneumonia and Pneumococcal Meningitis
7.1.13 Jan 25, 2016: Thermo Fisher Scientific Launches New B•R•A•H•M•S PCT Testing Solution in Europe for the Samsung IB10 Point-of-Care Platform
7.1.14 Jan 15, 2016: Premaitha Health welcomes recommendation for NHS provision of non-invasive prenatal testing
7.1.15 Dec 17, 2015: Stephen C. Farrell Appointed to STAAR Surgical Board of Directors
7.2 Financial Announcements
7.2.1 Nov 03, 2016: STAAR Surgical Reports Third Quarter 2016 Results
7.2.2 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results
7.2.3 Aug 09, 2016: Ocular Therapeutix Reports Second Quarter 2016 Financial Results and Provides Corporate Update
7.2.4 Aug 03, 2016: STAAR Surgical Reports Second Quarter 2016 Results
7.2.5 Aug 01, 2016: Glaukos Announces Second Quarter 2016 Financial Results
7.2.6 Jul 27, 2016: Anika Reports Second Quarter 2016 Financial Results
7.2.7 May 18, 2016: Wake Forest Baptist Fiscal Year 2016 Third Quarter Financial Performance
7.2.8 May 13, 2016: Wake Forest Baptist Reports Record $376.3 Million in Community Benefits during 2015 Fiscal Year
7.2.9 May 11, 2016: STAAR Surgical Reports First Quarter 2016 Results
7.2.10 May 11, 2016: Nephros Reports First Quarter 2016 Financial Results
7.2.11 May 10, 2016: Ocular Therapeutix Reports First Quarter 2016 Financial Results and Provides Corporate Update
7.2.12 Mar 02, 2016: STAAR Surgical Reports Fourth Quarter and Full Year 2015 Results
7.2.13 Feb 29, 2016: Wake Forest Baptist Fiscal Year 2016 Second Quarter Financial Performance
7.3 Legal And Regulatory
7.3.1 Jun 30, 2016: Wake Forest Baptist Receives Specialty Pharmacy Accreditation
7.3.2 Jan 21, 2016: Test could lead to more effective leukaemia treatment
7.3.3 Jan 14, 2016: Siemens Receives FDA Clearance for Biograph Horizon PET/CT System
7.4 Other Significant Developments
7.4.1 Jan 11, 2016: Bausch + Lomb Announces 2016 Elite Vendor Relationship with Vision Source
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Cataract Surgery Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 2: Cataract Surgery Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 3: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 4: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 5: Cataract Surgery Devices Market, United States, Volume (Units), Historic, 2008-2015
Table 6: Cataract Surgery Devices Market, United States, Volume (Units), Forecast, 2015-2022
Table 7: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), Historic, 2008-2015
Table 8: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), Forecast, 2015-2022
Table 9: Cataract Surgery Devices Market, United States, Average Price ($) Historic, 2008-2022
Table 10: Cataract Surgery Devices Market, United States, Average Price ($), Forecast, 2015-2022
Table 11: Cataract Surgery Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 12: Cataract Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2015
Table 13: Cataract Surgery Devices Market Pipeline Products
Table 14: Johnson & Johnson to Acquire Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion
Table 15: ReVision Optics Secures USD10 Million from Square 1 Bank
1.2 List of Figures
Figure 1: Cataract Surgery Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 2: Cataract Surgery Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 3: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 4: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 5: Cataract Surgery Devices Market, United States, Volume (Units), Historic, 2008-2015
Figure 6: Cataract Surgery Devices Market, United States, Volume (Units), Forecast, 2015-2022
Figure 7: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), Historic, 2008-2015
Figure 8: Ophthalmic Viscoelastic Devices (OVD) Market, United States, Volume (Units), Forecast, 2015-2022
Figure 9: Cataract Surgery Devices Market, United States, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report